Norethisterone transdermal - AbbVie
Alternative Names: NEA TDS; Norethindrone acetate patch; Norethindrone transdermal - AbbVie; Progestin-only patchLatest Information Update: 02 Oct 2021
At a glance
- Originator Watson Pharmaceuticals
- Developer AbbVie
- Class Hormonal replacements; Norpregnenes; Oral contraceptives; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pregnancy